Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Xavier Vallès is active.

Publication


Featured researches published by Xavier Vallès.


Tropical Medicine & International Health | 2006

Invasive pneumococcal disease in children <5 years of age in rural Mozambique

Anna Roca; Betuel Sigaúque; Ll. Quintó; Inacio Mandomando; Xavier Vallès; Mateu Espasa; Fatima Abacassamo; Jahit Sacarlal; Eusebio Macete; A. Nhacolo; Myron M. Levine; Pedro L. Alonso

Objectives  To estimate the incidence and epidemiological characteristics of invasive pneumococcal disease (IPD) in children <5 years of age living in a rural area of southern Mozambique.


Tropical Medicine & International Health | 2009

Invasive non‐typhoidal Salmonella in Mozambican children

Inacio Mandomando; Eusebio Macete; Betuel Sigaúque; Luis Morais; Llorenç Quintó; Jahit Sacarlal; Mateu Espasa; Xavier Vallès; Quique Bassat; Pedro Aide; Tacilta Nhampossa; Sonia Machevo; Joaquim Ruiz; Ariel Nhacolo; Clara Menéndez; Karen L. Kotloff; Anna Roca; Myron M. Levine; Pedro L. Alonso

Objective  To describe the epidemiology and clinical presentation of invasive non‐typhoidal Salmonella (NTS) in Mozambique.


Tropical Medicine & International Health | 2006

Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique

Xavier Vallès; Brendan Flannery; Anna Roca; Inacio Mandomando; Betuel Sigaúque; Sergi Sanz; Anne Schuchat; Myron Levine; Montserrat Soriano‐Gabarró; Pedro L. Alonso

Objective  To describe and compare serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae from children in rural Mozambique.


Antimicrobial Agents and Chemotherapy | 2009

Antimicrobial Susceptibility and Mechanisms of Resistance in Shigella and Salmonella Isolates from Children under Five Years of Age with Diarrhea in Rural Mozambique

Inacio Mandomando; Dinis Jaintilal; Maria J. Pons; Xavier Vallès; Mateu Espasa; Laura Mensa; Betuel Sigaúque; Sergi Sanz; Jahit Sacarlal; Eusebio Macete; Fatima Abacassamo; Pedro L. Alonso; Joaquim Ruiz

ABSTRACT The antimicrobial susceptibility and mechanisms of resistance of 109 Shigella and 40 Salmonella isolates from children with diarrhea in southern Mozambique were assessed. The susceptibility to seven antimicrobial agents was tested by disk diffusion, and mechanisms of resistance were searched by PCR or colorimetric method. A high proportion of Shigella isolates were resistant to chloramphenicol (Chl) (52%), ampicillin (Amp) (56%), tetracycline (Tet) (66%), and trimethoprim-sulfamethoxazole (Sxt) (84%). Sixty-five percent of the isolates were multidrug resistant. Shigella flexneri isolates were more resistant than those of Shigella sonnei to Amp (66% versus 0.0%, P < 0.001) and Chl (61% versus 0.0%, P < 0.001), whereas S. sonnei isolates presented higher resistance to Tet than S. flexneri isolates (93% versus 64%, P = 0.02). Resistance among Salmonella isolates was as follows: Tet and Chl, 15% each; Sxt, 18%; and Amp, 25%. Only 3% of Salmonella isolates were resistant to nalidixic acid (Nal), and none to ciprofloxacin or ceftriaxone (Cro). Among Salmonella isolates, multiresistance was found in 23%. Among Shigella isolates, antibiotic resistance was related mainly to the presence of oxa-1-like β-lactamases for Amp, dfrA1 genes for Sxt, tetB genes for Tet, and Chl acetyltransferase (CAT) activity for Chl. Among Salmonella isolates, resistance was conferred by tem-like β-lactamases for Amp, floR genes and CAT activity for Chl, tetA genes for Tet, and dfrA1 genes for Sxt. Our data show that Shigella isolates are resistant mostly to the most available, inexpensive antibiotics by various molecular mechanisms but remain susceptible to ciprofloxacin, Cro, and Nal, which is the first line for empirical treatment of shigellosis in the country.


American Journal of Tropical Medicine and Hygiene | 2010

Antimicrobial Drug Resistance Trends of Bacteremia Isolates in a Rural Hospital in Southern Mozambique

Inacio Mandomando; Betuel Sigaúque; Luis Morais; Mateu Espasa; Xavier Vallès; Jahit Sacarlal; Eusebio Macete; Pedro Aide; Llorenç Quintó; Tacilta Nhampossa; Sonia Machevo; Quique Bassat; Clara Menéndez; Joaquim Ruiz; Anna Roca; Pedro L. Alonso

Antibiotic resistance in Africa is increasing but insufficiently recognized as a public health problem. However, there are scarce data for antimicrobial resistance trends among bloodstream isolates in sub-Saharan Africa. Antimicrobial drug resistance trends among bacteria isolated from blood of children < 15 years of age admitted to the Manhiça District Hospital in Mozambique during May 2001-April 2006 were monitored by disk diffusion. We documented a linear trend of increasing resistance throughout the study period to chloramphenicol among isolates of Non-typhi Salmonella (P < 0.001), Escherichia coli (P = 0.002), Staphylococcus aureus (P < 0.001), and Haemophilus influenzae (P < 0.001). Increasing resistance to ampicillin was also observed for H. influenzae isolates (P < 0.001). We report trends of increasing resistance among the most frequent etiologies of bacteremia to the most commonly used antibiotics for empirical therapy in this community. Quinolones and third-generation cephalosporines may be needed in the short term to manage community-acquired infections.


Respiratory Research | 2014

Predicting treatment failure in patients with community acquired pneumonia: a case-control study

Ignacio Martin-Loeches; Xavier Vallès; Rosario Menéndez; Oriol Sibila; Beatriz Montull; Catia Cillóniz; Antonio Artigas; Antoni Torres

IntroductionTreatment failure in community-acquired-pneumonia (CAP) patients is associated with a high mortality rate, and therefore are a matter of great concern in clinical management. Those patients have increased mortality and are a target population for randomized clinical trials.MethodsA case–control study was performed in patients with CAP (non-failure cases vs. failure cases, discriminating by late and early failure). CRP, PCT, interleukin 1, 6, 8 and 10 and TNF were determined at days 1 and 3 of hospitalization.ResultsA total of 253 patients were included in this study where 83 patients presented treatment failure. Of these, 40 (48.2%) had early failure. A discriminative effect was found for a higher CURB-65 score among late failure patients (p = 0.004). A significant increase on day 1 of hospitalization in CRP (p < 0.001), PCT (p = 0.004), IL-6 (p < 0.001) and IL-8 (p = 0.02), and a decrease in IL-1 (p = 0.06) in patients with failure was observed compared with patients without failure. On day 3, only the increase in CRP (p < 0.001), PCT (p = 0.007) and IL-6 (p < 0.001) remained significant. Independent predictors for early failure were higher IL-6 levels on day 1 (OR = 1.78, IC = 1.2-2.6) and pleural effusion (OR = 2.25, IC = 1.0-5.3), and for late failure, higher PCT levels on day 3 (OR = 1.60, IC = 1.0-2.5), CURB-65 score ≥ 3 (OR = 1.43, IC = 1.0-2.0), and multilobar involvement (OR = 4.50, IC = 2.1-9.9).ConclusionsThere was a good correlation of IL-6 levels and CAP failure and IL-6 & PCT with late CAP failure. Pleural effusion and multilobar involvement were simple clinical predictors of early and late failure, respectively.Trial registrationIRB Register: http://2009/5451.


Pediatric Infectious Disease Journal | 2007

Epidemiology and clinical presentation of shigellosis in children less than five years of age in rural Mozambique.

Inacio Mandomando; Betuel Sigaúque; Xavier Vallès; Mateu Espasa; Sergi Sanz; Jahit Sacarlal; Eusebio Macete; Fatima Abacassamo; Joaquim Ruiz; Joaquim Gascón; Karen L. Kotloff; Myron M. Levine; Pedro L. Alonso

Rectal swabs were collected from 1354 children <5 years of age with diarrhea attending Manhiça District Hospital and from 227 healthy community controls. Shigellosis incidence was high among children aged 12–47 months (488.4/105 child-years at risk). Fever and dysentery were prominent clinical findings. Shigella was more frequently isolated from cases than controls (6.7% versus 0.4%, P = 0.004), and from dysentery than nondysenteric diarrhea (24.1% versus 3.5%, P < 0.001). Shigella flexneri 2a, S. sonnei, and S. flexneri 6, were the most prevalent serotypes.


American Journal of Tropical Medicine and Hygiene | 2011

Assessment of the Epidemiology and Burden of Measles in Southern Mozambique

Inacio Mandomando; Denise Naniche; Marcela F. Pasetti; Lilian Cuberos; Sergi Sanz; Xavier Vallès; Betuel Sigaúque; Eusebio Macete; Delino Nhalungo; Karen L. Kotloff; Myron M. Levine; Pedro L. Alonso

Measles has been a major killer among vaccine-preventable diseases in children < 5 years of age in developing countries. Despite progress in global efforts to reduce mortality, measles remains a public health problem. Hospital-based measles surveillance was conducted in Manhica, Mozambique (July 2001-September 2004). Suspected cases and community-based controls were enrolled, and blood was collected for immunoglobulin M (IgM) confirmation. Two hundred fifty-three suspected cases and 477 controls were enrolled, with 85% (216 of 253) cases reported during a measles outbreak. Measles-IgM confirmation was 30% among suspected cases and 5% in controls. Fifty-eight percent (14 of 24) of laboratory-confirmed cases had records indicating previous measles vaccination. Mortality was 3% (8 of 246) among cases and 1% among controls (6 of 426). Forty-five percent (33 of 74) of cases were < 24 months of age and 22% occurred in infants < 9 months of age and were associated with a high case-fatality rate (25%). Our data suggest that improved diagnostics, new tools to protect infants < 9 months of age, and a supplemental dose of measles vaccine could assist measles control.


American Journal of Tropical Medicine and Hygiene | 2007

ETIOLOGY OF DIARRHEA IN CHILDREN YOUNGER THAN 5 YEARS OF AGE ADMITTED IN A RURAL HOSPITAL OF SOUTHERN MOZAMBIQUE

Inacio Mandomando; Eusebio Macete; Joaquim Ruiz; Sergi Sanz; Fatima Abacassamo; Xavier Vallès; Jahit Sacarlal; Margarita M. Navia; Jordi Vila; Pedro L. Alonso; Joaquim Gascón


Journal of Antimicrobial Chemotherapy | 2007

Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique

Inacio Mandomando; Mateu Espasa; Xavier Vallès; Jahit Sacarlal; Betuel Sigaúque; Joaquim Ruiz; Pedro L. Alonso

Collaboration


Dive into the Xavier Vallès's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jahit Sacarlal

Eduardo Mondlane University

View shared research outputs
Top Co-Authors

Avatar

Mateu Espasa

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Joaquim Ruiz

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Sergi Sanz

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fatima Abacassamo

Eduardo Mondlane University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge